SynthesisAsian Pacific journal of cancer prevention : APJCP2026
Micronuclei in the Buccal Mucosal Cells are Genotoxicity Markers in Oral Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.
Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMicronuclei (MN) genotoxicity, linked to chromosomal anomalies, is a key biomarker for carcinogen exposure and cancer susceptibility, with higher frequencies observed in cancer patients. The micronuclei assay, using exfoliated buccal cells, offers a non-invasive method for diagnosing oral lesions caused by tobacco, betel nut, and alcohol. This review aims to systematically review micronuclei frequencies in buccal mucosal cells and assess their potential as genotoxicity markers in oral potentially malignant disorders (OPMD).
methodsA systematic search updated to 2024 was conducted using PubMed, Scopus, ProQuest, Cochrane, and Google Scholar for original studies analyzing micronuclei frequencies in buccal cells as genotoxicity markers for OPMD. Studies including leukoplakia, lichen planus, and OSMF, were selected. The assessment of risk bias was done using modified Newcastle-Ottawa Scale followed by meta- analysis. The review was registered in PROSPERO (Registration No. CRD42024536661). Results: Twenty-six articles encompassing a pooled sample of 1,078 healthy controls and 1,489 OPMD cases (417 leukoplakia, 180 oral lichen planus, 401 OSMF, and 491 unsegregated OPMDs) were included. A significant increase in micronuclei frequency was observed in OPMD patients compared to controls (meta-Cohen's d = 3.08, 95% CI: 1.80-4.35). Subgroup analysis revealed a gradual rise in MN frequency from healthy controls to leukoplakia (d = 2.75), oral lichen planus (d = 1.47), and the highest in oral submucous fibrosis (d = 5.55). Considerable heterogeneity was detected among studies (overall I² = 99.23%, OSMF I² = 99.85%, lichen planus I² = 49.59%). This variability highlights methodological and population differences across studies.
conclusionMicronuclei genotoxicity is emerging as a valuable biomarker for the early detection of OPMD's. Due to its non-invasive and cost-efficient characteristics, examining micronuclei in exfoliated buccal cells could be incorporated into regular screenings for groups at high risk of OPMD and oral cancer. However, the considerable variability among studies necessitates careful interpretation and highlights the importance of establishing standardized protocols in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.